Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)

NCT01276509 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT01276509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01276509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Lead sponsor
Shire
Phase
Phase 2
Overall status
Completed
Start date
April 6, 2011
Completion date
October 9, 2015
Enrollment
265 (actual)
Sites
137

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease